COMMENTARY

• COMMENTARY／Pharma Industry Watches New DPJ Administration with Both Anticipation and Concerns
  September 21, 2009

• COMMENTARY／Will It Be Possible to Eliminate Use of Multiple Antipsychotics in Massive Doses?
  September 14, 2009

• COMMENTARY／Establish Solid Criteria for Switching Ethical Drugs to OTC Status
  September 14, 2009

• COMMENTARY／Korosho to Embark on Japanese Version of Sentinel Initiative
  September 7, 2009

• COMMENTARY／Wholesalers Need to Analyze Causes of Their Failure
  August 24, 2009

• COMMENTARY／Hisamitsu Aims at Growth by Fusing Its and Noven's Technologies
  August 24, 2009

• COMMENTARY／Permitting MSs to Take MR Cert. Exam Offers New Business Opportunity to Wholesalers
  August 3, 2009

• COMMENTARY／Fair Profits Are Essential to Spread Regenerative Medicine
  August 3, 2009

• Hitech Drugs Open the Window to the Future- With Special Focus on Development and Marketing -(1)
  July 20, 2009

• Hitech Drugs Open the Window to the Future- With Special Focus on Development and Marketing -(2)
  July 20, 2009

• COMMENTARY／Global Pharmas Enhance Their Presence in Japan
  July 13, 2009

• COMMENTARY／Additional Price Cuts for Long-listed Original Drugs
  June 29, 2009

• COMMENTARY／Clinical Applications of ADCs Coming Closer to Reality
  June 29, 2009

• SURVEY／RLS Takes Almost Four Years before Being Diagnosed
  June 22, 2009

• COMMENTARY／JSHP to Promote Use of Generics
  June 8, 2009

• COMMENTARY／Combination Drugs Becoming a "Boom"
  June 1, 2009

• COMMENTARY／Clearer Criteria Needed for Patent Period Restoration
  May 4, 2009

• COMMENTARY／Why Does the Use of Generics Not Increase?
  April 27, 2009

• EMTs Allowed to Administer Epipen
  April 27, 2009

• COMMENTARY／Medway Data Falsification to Make Blood Product Self-Sufficiency Difficult
  April 20, 2009

ページ